-
Butyrate, Lysosomal Iron, and Lung Cancer Stemness
2026-09-04
The reference study shows that butyrate suppresses lung cancer stemness through a ferroptotic mechanism involving lysosomal Fe2+ recruitment and reduced SLC7A11 protein stability. Its integrated sphere-formation, molecular, migration, chemotherapy-sensitivity, and tumorigenesis experiments provide a useful framework for connecting metabolic regulation with cancer stem cell vulnerability.
-
circEIF2S2 in Colorectal Cancer Progression
2026-09-04
The reference study identifies an EIF4A3–circEIF2S2–miR-646–UHMK1 regulatory axis that connects circular RNA biogenesis with colorectal cancer growth, metastasis, and immune suppression. Its combination of expression profiling, loss-of-function experiments, rescue studies, immune co-culture, and xenograft models provides a mechanistic framework for evaluating circEIF2S2 as a potential biomarker and therapeutic target.
-
Hsa_circ_0001944, FXR/TLR4, and NiONP Fibrosis
2026-09-04
A 2025 Toxics study identifies hsa_circ_0001944 as a regulatory link connecting FXR/TLR4 signaling, ferroptosis, and nickel oxide nanoparticle-induced collagen deposition in LX-2 hepatic stellate cells. Pharmacological perturbation and circRNA overexpression together provide a mechanistic framework for studying toxicant-associated liver fibrosis, while the cell-based design limits direct translation to human disease.
-
Triazole ALDH2 Activators in Myocardial Ischemia
2026-09-03
The reference study combines molecular simulation, triazole scaffold design, biochemical testing, and mouse ischemia–reperfusion experiments to identify Z17 as a highly active ALDH2 activator. Z17 improved cardiac function and reduced biochemical and histological indicators of myocardial injury, while its improved water solubility addresses a limitation of earlier ALDH2 activators.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-02
Turn JC-1 fluorescence into a practical readout of mitochondrial stress, apoptosis, and treatment response. This workflow emphasizes ratio-based analysis, CCCP controls, and application-specific optimization for cancer and mitochondrial research.
-
SVA 3A/2B Counter DDX23 Through Apoptosis
2026-09-02
Li et al. show that DDX23 restricts Senecavirus A (SVA) replication through caspase-dependent degradation of viral 3A, while SVA 2B promotes DDX23 loss through a distinct caspase pathway. The study combines host-factor perturbation, protein-interaction experiments, caspase inhibition, and reverse genetics to identify amino acid determinants that may guide antiviral and vaccine research.
-
ATF4–H2S Protection in Doxorubicin Cardiomyopathy
2026-09-01
This preprint identifies a KLF16–ATF4–CSE axis that limits doxorubicin-induced cardiac oxidative stress by sustaining hydrogen sulfide production. Genetic loss and AAV9-mediated overexpression experiments connect ATF4 activity with cardiac function, survival, reactive oxygen species, and apoptosis, providing a mechanistic framework for cardiotoxicity model design.
-
ML216 BLM Helicase Inhibitor: Lab Workflows
2026-09-01
ML216 supports mechanism-focused studies of BLM-dependent DNA repair, from helicase unwinding assays and sister chromatid exchange measurements to cell proliferation and chemotherapy-sensitization experiments. This guide pairs practical formulation and dosing strategies with controls that help distinguish on-target BLM helicase inhibition from nonspecific cytotoxicity.
-
QNZ (EVP4593): From NF-κB Biology to Translation
2026-08-31
A translational framework for using QNZ (EVP4593) to connect NF-κB reporter activity, TNF-α biology, inflammation models, and Huntington’s disease research while maintaining evidence boundaries.
-
Cefodizime: From PBP Biology to Resistance Strategy
2026-08-31
Cefodizime is more than a broad-spectrum antibacterial agent: it is a useful translational probe for connecting penicillin-binding protein biology, susceptibility testing, immune-response assays, pharmacokinetic context, and antimicrobial stewardship. This article outlines how researchers can use Cefodizime to design more informative infection models while interpreting resistance surveillance with appropriate caution.
-
Z-VDVAD-FMK for Apoptosis Assays
2026-08-30
Z-VDVAD-FMK provides a cell-permeable, irreversible way to interrogate caspase-2-centered apoptosis alongside mitochondrial signaling and downstream caspase activity. This guide turns that mechanism into a practical workflow for cancer research while showing how to avoid confusing apoptotic rescue with caspase-1-driven pyroptosis.
-
BIBR 1532 for Reliable Telomerase Assays
2026-08-29
This scenario-driven guide explains how BIBR 1532 (SKU A1945) can improve the interpretation and reproducibility of telomerase, proliferation, viability, and apoptosis workflows. It covers solvent handling, concentration design, orthogonal readouts, leukemia-model interpretation, and practical supplier evaluation.
-
Brefeldin A: From Trafficking Block to ER Stress
2026-08-28
Brefeldin A is more than a vesicle transport inhibitor: it is a practical probe for connecting ER–Golgi trafficking failure with protein quality control and cell fate. This guide translates its mechanism, ER stress biology, and cancer-model evidence into better assay design.
-
GCRV Entry via Clathrin-Mediated Endocytosis
2026-08-28
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to show that genotype III grass carp reovirus GCRV104 enters CIK cells through a clathrin-mediated, dynamin-dependent, acidification-sensitive pathway. The study also demonstrates that Latrunculin B did not significantly inhibit infection under the tested conditions, an important negative result for interpreting actin-directed perturbations in viral entry research.
-
MLN4924 HCl Salt: A Mechanistic Assay Guide
2026-08-27
MLN4924 HCl salt is a selective NEDD8-activating enzyme inhibitor for dissecting cullin-RING ligase activity, proteostasis, and cell fate. This guide translates viral RIPK3-degradation research into a rigorous assay strategy that separates pathway engagement from downstream biological interpretation.